Gemcitabine causes telomere attrition by stabilizing TRF2.

[1]  H. Ueno,et al.  Population Pharmacokinetics of Gemcitabine and Its Metabolite in Japanese Cancer Patients , 2010, Clinical pharmacokinetics.

[2]  G. Capellá,et al.  Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model , 2008, Molecular Cancer Therapeutics.

[3]  P. Klatt,et al.  Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis. , 2007, Genes & development.

[4]  E. Friedberg,et al.  TERF2-XPF: caught in the middle; beginnings from the end. , 2006, DNA repair.

[5]  M. Blasco,et al.  XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer , 2005, Nature Genetics.

[6]  R. Reddel,et al.  Telomere Biology: A New Player in the End Zone , 2004, Current Biology.

[7]  A. Smogorzewska,et al.  Regulation of telomerase by telomeric proteins. , 2004, Annual review of biochemistry.

[8]  A. Depierre,et al.  Gemcitabine induction chemotherapy in non-small cell lung cancer. , 2002, Seminars in oncology.

[9]  V. Heinemann.  Present and future treatment of pancreatic cancer. , 2002, Seminars in oncology.

[10]  E. Perez,et al.  Gemcitabine and targeted therapy in metastatic breast cancer. , 2002, Seminars in oncology.

[11]  D. Hedley,et al.  Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity. , 2000, Cancer research.

[12]  D. Fleming,et al.  Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies. , 2000, American journal of clinical oncology.

[13]  B. van Steensel,et al.  Control of Human Telomere Length by TRF1 and TRF2 , 2000, Molecular and Cellular Biology.

[14]  T. Wang,et al.  Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis. , 1998, Cancer research.

[15]  V A Zakian,et al.  Telomeres: Beginning to Understand the End , 1995, Science.

[16]  Keiko Hiyama,et al.  Correlating telomerase activity levels with human neuroblastoma outcomes , 1995, Nature Medicine.

[17]  Benjamin Rs.  Gemcitabine: a modulator of intracellular nucleotide and deoxynucleotide metabolism. , 1995 .

[18]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[19]  G. Peters,et al.  Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours. , 1994, Biochemical pharmacology.

[20]  C. Harley,et al.  Telomerase activity in human ovarian carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  W. E. Schy,et al.  Effect of a template-located 2',2'-difluorodeoxycytidine on the kinetics and fidelity of base insertion by Klenow (3'-->5'exonuclease-) fragment. , 1993, Cancer research.

[22]  J. Steitz,et al.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.

[23]  Y Z Xu,et al.  Cellular elimination of 2',2'-difluorodeoxycytidine 5'-triphosphate: a mechanism of self-potentiation. , 1992, Cancer research.

[24]  J. Bollinger,et al.  2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase. , 1991, Journal of medicinal chemistry.

[25]  E. Blackburn,et al.  Structure and function of telomeres , 1991, Nature.

[26]  R. Myers,et al.  Structure and variability of human chromosome ends , 1990, Molecular and cellular biology.

[27]  G. Morin.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats , 1989, Cell.

[28]  R. Moyzis,et al.  Conservation of the human telomere sequence (TTAGGG)n among vertebrates. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  V A Zakian,et al.  Structure and function of telomeres. , 1989, Annual review of genetics.

[30]  L. S. Cram,et al.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Tjian,et al.  Affinity purification of sequence-specific DNA binding proteins. , 1986, Proceedings of the National Academy of Sciences of the United States of America.